Table of Content

1 Attenuated Vaccine Market Overview
1.1 Attenuated Vaccine Product Overview
1.2 Attenuated Vaccine Market Segment by Type
1.2.1 Bacterial Vaccine
1.2.2 Viral Vaccine
1.3 Global Attenuated Vaccine Market Size by Type
1.3.1 Global Attenuated Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Attenuated Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Attenuated Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Attenuated Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Attenuated Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Attenuated Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Attenuated Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Attenuated Vaccine Sales Breakdown by Type (2024-2024)
2 Global Attenuated Vaccine Market Competition by Company
2.1 Global Top Players by Attenuated Vaccine Sales (2024-2024)
2.2 Global Top Players by Attenuated Vaccine Revenue (2024-2024)
2.3 Global Top Players by Attenuated Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Attenuated Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Attenuated Vaccine Market Competitive Situation and Trends
2.5.1 Attenuated Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Attenuated Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Attenuated Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Attenuated Vaccine Market
2.8 Key Manufacturers Attenuated Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Attenuated Vaccine Status and Outlook by Region
3.1 Global Attenuated Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Attenuated Vaccine Historic Market Size by Region
3.2.1 Global Attenuated Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Attenuated Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Attenuated Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Attenuated Vaccine Forecasted Market Size by Region
3.3.1 Global Attenuated Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Attenuated Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Attenuated Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Attenuated Vaccine by Application
4.1 Attenuated Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Attenuated Vaccine Market Size by Application
4.2.1 Global Attenuated Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Attenuated Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Attenuated Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Attenuated Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Attenuated Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Attenuated Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Attenuated Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Attenuated Vaccine Sales Breakdown by Application (2024-2024)
5 North America Attenuated Vaccine by Country
5.1 North America Attenuated Vaccine Historic Market Size by Country
5.1.1 North America Attenuated Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Attenuated Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Attenuated Vaccine Sales in Value by Country (2024-2024)
5.2 North America Attenuated Vaccine Forecasted Market Size by Country
5.2.1 North America Attenuated Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Attenuated Vaccine Sales in Value by Country (2024-2034)
6 Europe Attenuated Vaccine by Country
6.1 Europe Attenuated Vaccine Historic Market Size by Country
6.1.1 Europe Attenuated Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Attenuated Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Attenuated Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Attenuated Vaccine Forecasted Market Size by Country
6.2.1 Europe Attenuated Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Attenuated Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Attenuated Vaccine by Region
7.1 Asia-Pacific Attenuated Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Attenuated Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Attenuated Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Attenuated Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Attenuated Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Attenuated Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Attenuated Vaccine Sales in Value by Region (2024-2034)
8 Latin America Attenuated Vaccine by Country
8.1 Latin America Attenuated Vaccine Historic Market Size by Country
8.1.1 Latin America Attenuated Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Attenuated Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Attenuated Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Attenuated Vaccine Forecasted Market Size by Country
8.2.1 Latin America Attenuated Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Attenuated Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Attenuated Vaccine by Country
9.1 Middle East and Africa Attenuated Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Attenuated Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Attenuated Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Attenuated Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Attenuated Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Attenuated Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Attenuated Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck & Co.
10.1.1 Merck & Co. Company Information
10.1.2 Merck & Co. Introduction and Business Overview
10.1.3 Merck & Co. Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck & Co. Attenuated Vaccine Products Offered
10.1.5 Merck & Co. Recent Development
10.2 GlaxoSmithKline plc
10.2.1 GlaxoSmithKline plc Company Information
10.2.2 GlaxoSmithKline plc Introduction and Business Overview
10.2.3 GlaxoSmithKline plc Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 GlaxoSmithKline plc Attenuated Vaccine Products Offered
10.2.5 GlaxoSmithKline plc Recent Development
10.3 Pfizer Inc
10.3.1 Pfizer Inc Company Information
10.3.2 Pfizer Inc Introduction and Business Overview
10.3.3 Pfizer Inc Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Pfizer Inc Attenuated Vaccine Products Offered
10.3.5 Pfizer Inc Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Sanofi Attenuated Vaccine Products Offered
10.4.5 Sanofi Recent Development
10.5 Astellas Pharma
10.5.1 Astellas Pharma Company Information
10.5.2 Astellas Pharma Introduction and Business Overview
10.5.3 Astellas Pharma Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Astellas Pharma Attenuated Vaccine Products Offered
10.5.5 Astellas Pharma Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Johnson & Johnson Attenuated Vaccine Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 CSL Limited
10.7.1 CSL Limited Company Information
10.7.2 CSL Limited Introduction and Business Overview
10.7.3 CSL Limited Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 CSL Limited Attenuated Vaccine Products Offered
10.7.5 CSL Limited Recent Development
10.8 Serum Institute of India Pvt. Ltd.
10.8.1 Serum Institute of India Pvt. Ltd. Company Information
10.8.2 Serum Institute of India Pvt. Ltd. Introduction and Business Overview
10.8.3 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Products Offered
10.8.5 Serum Institute of India Pvt. Ltd. Recent Development
10.9 Biken
10.9.1 Biken Company Information
10.9.2 Biken Introduction and Business Overview
10.9.3 Biken Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Biken Attenuated Vaccine Products Offered
10.9.5 Biken Recent Development
10.10 Green Cross Corporation
10.10.1 Green Cross Corporation Company Information
10.10.2 Green Cross Corporation Introduction and Business Overview
10.10.3 Green Cross Corporation Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Green Cross Corporation Attenuated Vaccine Products Offered
10.10.5 Green Cross Corporation Recent Development
10.11 Shanghai Rongsheng Biotech
10.11.1 Shanghai Rongsheng Biotech Company Information
10.11.2 Shanghai Rongsheng Biotech Introduction and Business Overview
10.11.3 Shanghai Rongsheng Biotech Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Shanghai Rongsheng Biotech Attenuated Vaccine Products Offered
10.11.5 Shanghai Rongsheng Biotech Recent Development
10.12 Changchun BCHT Biotechnology Co.,Ltd
10.12.1 Changchun BCHT Biotechnology Co.,Ltd Company Information
10.12.2 Changchun BCHT Biotechnology Co.,Ltd Introduction and Business Overview
10.12.3 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Products Offered
10.12.5 Changchun BCHT Biotechnology Co.,Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Attenuated Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Attenuated Vaccine Industrial Chain Analysis
11.4 Attenuated Vaccine Market Dynamics
11.4.1 Attenuated Vaccine Industry Trends
11.4.2 Attenuated Vaccine Market Drivers
11.4.3 Attenuated Vaccine Market Challenges
11.4.4 Attenuated Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Attenuated Vaccine Distributors
12.3 Attenuated Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Bacterial Vaccine
Table 2. Major Company of Viral Vaccine
Table 3. Global Attenuated Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Attenuated Vaccine Sales by Type (2024-2024) & (K Doses)
Table 5. Global Attenuated Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Attenuated Vaccine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Attenuated Vaccine Market Share in Value by Type (2024-2024)
Table 8. Global Attenuated Vaccine Price by Type (2024-2024) & (US$/Dose)
Table 9. Global Attenuated Vaccine Sales by Type (2024-2034) & (K Doses)
Table 10. Global Attenuated Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Attenuated Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Attenuated Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Attenuated Vaccine Price by Type (2024-2034) & (US$/Dose)
Table 14. North America Attenuated Vaccine Sales by Type (2024-2024) & (K Doses)
Table 15. North America Attenuated Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Attenuated Vaccine Sales (K Doses) by Type (2024-2024)
Table 17. Europe Attenuated Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Attenuated Vaccine Sales (K Doses) by Type (2024-2024)
Table 19. Asia-Pacific Attenuated Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Attenuated Vaccine Sales (K Doses) by Type (2024-2024)
Table 21. Latin America Attenuated Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Attenuated Vaccine Sales (K Doses) by Type (2024-2024)
Table 23. Middle East and Africa Attenuated Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Attenuated Vaccine Sales by Company (2024-2024) & (K Doses)
Table 25. Global Attenuated Vaccine Sales Share by Company (2024-2024)
Table 26. Global Attenuated Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Attenuated Vaccine Revenue Share by Company (2024-2024)
Table 28. Global Market Attenuated Vaccine Price by Company (2024-2024) & (US$/Dose)
Table 29. Global Attenuated Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Attenuated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Attenuated Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Attenuated Vaccine Market
Table 33. Key Manufacturers Attenuated Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Attenuated Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Attenuated Vaccine Sales by Region (2024-2024) & (K Doses)
Table 37. Global Attenuated Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Attenuated Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Attenuated Vaccine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Attenuated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 41. Global Attenuated Vaccine Sales by Region (2024-2034) & (K Doses)
Table 42. Global Attenuated Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Attenuated Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Attenuated Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Attenuated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2034)
Table 46. Global Attenuated Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Attenuated Vaccine Sales by Application (2024-2024) & (K Doses)
Table 48. Global Attenuated Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Attenuated Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Attenuated Vaccine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Attenuated Vaccine Price by Application (2024-2024) & (US$/Dose)
Table 52. Global Attenuated Vaccine Sales by Application (2024-2034) & (K Doses)
Table 53. Global Attenuated Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Attenuated Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Attenuated Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Attenuated Vaccine Price by Application (2024-2034) & (US$/Dose)
Table 57. North America Attenuated Vaccine Sales by Application (2024-2024) (K Doses)
Table 58. North America Attenuated Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Attenuated Vaccine Sales by Application (2024-2024) (K Doses)
Table 60. Europe Attenuated Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Attenuated Vaccine Sales by Application (2024-2024) (K Doses)
Table 62. Asia-Pacific Attenuated Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Attenuated Vaccine Sales by Application (2024-2024) (K Doses)
Table 64. Latin America Attenuated Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Attenuated Vaccine Sales by Application (2024-2024) (K Doses)
Table 66. Middle East and Africa Attenuated Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Attenuated Vaccine Sales by Country (2024-2024) & (K Doses)
Table 68. North America Attenuated Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Attenuated Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Attenuated Vaccine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Attenuated Vaccine Sales by Country (2024-2034) & (K Doses)
Table 72. North America Attenuated Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Attenuated Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Attenuated Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Attenuated Vaccine Sales by Country (2024-2024) & (K Doses)
Table 76. Europe Attenuated Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Attenuated Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Attenuated Vaccine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Attenuated Vaccine Sales by Country (2024-2034) & (K Doses)
Table 80. Europe Attenuated Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Attenuated Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Attenuated Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Attenuated Vaccine Sales by Region (2024-2024) & (K Doses)
Table 84. Asia-Pacific Attenuated Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Attenuated Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Attenuated Vaccine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Attenuated Vaccine Sales by Region (2024-2034) & (K Doses)
Table 88. Asia-Pacific Attenuated Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Attenuated Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Attenuated Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Attenuated Vaccine Sales by Country (2024-2024) & (K Doses)
Table 92. Latin America Attenuated Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Attenuated Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Attenuated Vaccine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Attenuated Vaccine Sales by Country (2024-2034) & (K Doses)
Table 96. Latin America Attenuated Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Attenuated Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Attenuated Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Attenuated Vaccine Sales by Country (2024-2024) & (K Doses)
Table 100. Middle East and Africa Attenuated Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Attenuated Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Attenuated Vaccine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Attenuated Vaccine Sales by Country (2024-2034) & (K Doses)
Table 104. Middle East and Africa Attenuated Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Attenuated Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Attenuated Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Merck & Co. Company Information
Table 108. Merck & Co. Introduction and Business Overview
Table 109. Merck & Co. Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 110. Merck & Co. Attenuated Vaccine Product
Table 111. Merck & Co. Recent Development
Table 112. GlaxoSmithKline plc Company Information
Table 113. GlaxoSmithKline plc Introduction and Business Overview
Table 114. GlaxoSmithKline plc Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 115. GlaxoSmithKline plc Attenuated Vaccine Product
Table 116. GlaxoSmithKline plc Recent Development
Table 117. Pfizer Inc Company Information
Table 118. Pfizer Inc Introduction and Business Overview
Table 119. Pfizer Inc Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 120. Pfizer Inc Attenuated Vaccine Product
Table 121. Pfizer Inc Recent Development
Table 122. Sanofi Company Information
Table 123. Sanofi Introduction and Business Overview
Table 124. Sanofi Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 125. Sanofi Attenuated Vaccine Product
Table 126. Sanofi Recent Development
Table 127. Astellas Pharma Company Information
Table 128. Astellas Pharma Introduction and Business Overview
Table 129. Astellas Pharma Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 130. Astellas Pharma Attenuated Vaccine Product
Table 131. Astellas Pharma Recent Development
Table 132. Johnson & Johnson Company Information
Table 133. Johnson & Johnson Introduction and Business Overview
Table 134. Johnson & Johnson Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 135. Johnson & Johnson Attenuated Vaccine Product
Table 136. Johnson & Johnson Recent Development
Table 137. CSL Limited Company Information
Table 138. CSL Limited Introduction and Business Overview
Table 139. CSL Limited Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 140. CSL Limited Attenuated Vaccine Product
Table 141. CSL Limited Recent Development
Table 142. Serum Institute of India Pvt. Ltd. Company Information
Table 143. Serum Institute of India Pvt. Ltd. Introduction and Business Overview
Table 144. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 145. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product
Table 146. Serum Institute of India Pvt. Ltd. Recent Development
Table 147. Biken Company Information
Table 148. Biken Introduction and Business Overview
Table 149. Biken Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 150. Biken Attenuated Vaccine Product
Table 151. Biken Recent Development
Table 152. Green Cross Corporation Company Information
Table 153. Green Cross Corporation Introduction and Business Overview
Table 154. Green Cross Corporation Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 155. Green Cross Corporation Attenuated Vaccine Product
Table 156. Green Cross Corporation Recent Development
Table 157. Shanghai Rongsheng Biotech Company Information
Table 158. Shanghai Rongsheng Biotech Introduction and Business Overview
Table 159. Shanghai Rongsheng Biotech Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 160. Shanghai Rongsheng Biotech Attenuated Vaccine Product
Table 161. Shanghai Rongsheng Biotech Recent Development
Table 162. Changchun BCHT Biotechnology Co.,Ltd Company Information
Table 163. Changchun BCHT Biotechnology Co.,Ltd Introduction and Business Overview
Table 164. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 165. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product
Table 166. Changchun BCHT Biotechnology Co.,Ltd Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Attenuated Vaccine Market Trends
Table 170. Attenuated Vaccine Market Drivers
Table 171. Attenuated Vaccine Market Challenges
Table 172. Attenuated Vaccine Market Restraints
Table 173. Attenuated Vaccine Distributors List
Table 174. Attenuated Vaccine Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Attenuated Vaccine Product Picture
Figure 2. Global Attenuated Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Attenuated Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Attenuated Vaccine Sales Status and Outlook (2024-2034) & (K Doses)
Figure 5. Product Picture of Bacterial Vaccine
Figure 6. Global Bacterial Vaccine Sales YoY Growth (2024-2034) & (K Doses)
Figure 7. Product Picture of Viral Vaccine
Figure 8. Global Viral Vaccine Sales YoY Growth (2024-2034) & (K Doses)
Figure 9. Global Attenuated Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Attenuated Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Attenuated Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Attenuated Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Attenuated Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Attenuated Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Attenuated Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Attenuated Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Attenuated Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Attenuated Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Attenuated Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Attenuated Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Attenuated Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Attenuated Vaccine Revenue in 2022
Figure 23. Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Doses)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2024-2034) & (K Doses)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Doses)
Figure 30. Global Attenuated Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Attenuated Vaccine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Attenuated Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Attenuated Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Attenuated Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Attenuated Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Attenuated Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Attenuated Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Attenuated Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Attenuated Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Attenuated Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Attenuated Vaccine Manufacturing Cost Structure
Figure 43. Attenuated Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed